» Authors » Lucio Pallares

Lucio Pallares

Explore the profile of Lucio Pallares including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 407
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salman-Monte T, Cuadrado M, Galindo M, Espinosa G, Morales E, Pego-Reigosa J, et al.
Expert Opin Biol Ther . 2025 Mar; PMID: 40077897
Introduction: Belimumab (BEL), an anti B-lymphocyte stimulator monoclonal antibody, is the only approved biological therapy for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Areas Covered: This review discusses BEL's...
2.
Salman-Monte T, Mateo P, Izquierdo M, Cervera R, Lopez N, Pallares L, et al.
Clin Rheumatol . 2023 Dec; 43(2):847. PMID: 38047981
No abstract available.
3.
Fanlo P, Gracia-Tello B, Fonseca Aizpuru E, Alvarez-Troncoso J, Gonzalez A, Prieto-Gonzalez S, et al.
JAMA Netw Open . 2023 Apr; 6(4):e237243. PMID: 37027155
Importance: COVID-19 pneumonia is often associated with hyperinflammation. The efficacy and safety of anakinra in treating patients with severe COVID-19 pneumonia and hyperinflammation are still unclear. Objective: To assess the...
4.
Estevez M, Lanio N, Molina A, Jimenez-Leon M, Picado M, Esteban E, et al.
J Stroke Cerebrovasc Dis . 2023 Feb; 32(5):107034. PMID: 36842350
Objectives: Neurological manifestations compatible with small vessel brain lesions (SVBL), such as migraine, cognitive impairment, seizures, and transverse myelitis, may be related to antiphospholipid syndrome (APS) and patients could need...
5.
Salman-Monte T, Mateo P, Izquierdo M, Cervera R, Lopez N, Pallares L, et al.
Clin Rheumatol . 2023 Jan; 42(5):1259-1265. PMID: 36627527
Objectives: A survey conducted by the Spanish Lupus Federation (FELUPUS) shows the results on perceptions and experiences of the people who live with lupus in Spain. The information was gathered...
6.
Gracia B, Saez L, Pallares L, Velilla J, Marin A, Martinez-Lostao L, et al.
Front Med (Lausanne) . 2022 Feb; 8:808608. PMID: 35155485
Objectives: COVID-19 outcomes in population with systemic autoimmune diseases (SAD) remain poorly understood. The aim was to examine demographic and clinical factors associated with COVID-19 infection in people with rheumatic...
7.
Ramos-Casals M, Perez-Alvarez R, Kostov B, Gomez-de-la-Torre R, Feijoo-Masso C, Chara-Cervantes J, et al.
Sci Rep . 2021 Jul; 11(1):13735. PMID: 34215779
To analyze the frequency and clinical phenotype of neurosarcoidosis (NS) in one of the largest nationwide cohorts of patients with sarcoidosis reported from southern Europe. NS was evaluated according to...
8.
Prevete I, Espinosa G, Bellisai F, Bortoluzzi A, Conti F, Fredi M, et al.
Clin Exp Rheumatol . 2020 Jan; 38(5):925-932. PMID: 31969225
Objectives: To compare the main characteristics of two inception cohorts (Italian [ITC] and Spanish [SPC]) cohorts of patients with systemic lupus erythematosus (SLE) at the time of diagnosis and at...
9.
Ramos-Casals M, Retamozo S, Siso-Almirall A, Perez-Alvarez R, Pallares L, Brito-Zeron P
Expert Rev Clin Immunol . 2019 Jan; 15(4):391-405. PMID: 30632406
Sarcoidosis is a complex systemic disease with a silent, long-term evolution, and a heterogeneous clinical presentation. The diagnostic approach is complex with no single diagnostic test that may confirm the...
10.
Brito-Zeron P, Perez-Alvarez R, Pallares L, Retamozo S, Baughman R, Ramos-Casals M
Expert Opin Pharmacother . 2016 Nov; 17(18):2431-2448. PMID: 27817209
Sarcoidosis is a systemic disease of unknown etiology characterized by the development of non-caseating epitheloid granulomas. The lungs are the most commonly involved organ (>90% of cases), followed by the...